|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| G01N 33/50 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3221359 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15801637.8 |
| Date of filing the European patent application | 2015-11-17 | |
| (97) | Date of publication of the European application | 2017-09-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-27 |
| (46) | Date of publication of the claims translation | 2020-07-27 |
| (86) | Number | PCT/US2015/061139 |
| Date | 2015-11-17 |
| (87) | Number | WO 2016/081490 |
| Date | 2016-05-26 |
| (30) | Number | Date | Country code |
| 201462080716 P | 2014-11-17 | US | |
| 201562160788 P | 2015-05-13 | US |
| (72) |
SMITH, Eric, US
DAVIS, Samuel, US
VARGHESE, Bindu, US
KIRSHNER, Jessica R., US
THURSTON, Gavin, US
LOWY, Israel, US
BROWNSTEIN, Carrie, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Naviko gydymo būdai, naudojant CD3XCD20 bispecifinį antikūną |
| METHODS FOR TUMOR TREATMENT USING CD3XCD20 BISPECIFIC ANTIBODY |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 11 | 289.00 EUR |
| 2026-11-17 |